| abstract |
modified release formulations and uses thereof. The present invention relates to modified release compositions in a solid oral dosage form comprising amisulpride in the form of an unequal mixture of (r)-amisulpride and (s)-amisulpride, or pharmaceutically acceptable salts thereof, wherein the amount of ( r)-amisulpride is greater than the amount of (s)-amisulpride, and drugs comprising the same, used for the treatment of various diseases and disorders, and methods of using the same for the treatment of various diseases and disorders, including, however, not limited to dosage regimens. further, the present invention relates to formulations that use enantiomeric amisulpride polymorphs. |